Tiziana Life Sciences Ltd
TLSANext catalyst
Foralumab Nasal
Multiple System Atrophy
Get an email about TLSA's next catalysts
Track Tiziana Life Sciences (TLSA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 3 past
Foralumab Nasal Phase 2 Est. Readout
Estimated primary completion for Foralumab Nasal trial (NCT06868628) in Multiple System Atrophy. Topline data typically follows completion by weeks to months.
SourceHow TLSA's past catalysts played out
Market Overview
Stock performance and key metrics
Foralumab Nasal
Multiple System Atrophy
Foralumab
Secondary Progressive Multiple Sclerosis
Foralumab TZLS-401
Non-Active Secondary Progressive Multiple Sclerosis
Milciclib maleate
Hepatocellular Carcinoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Foralumab Nasal | Phase 2 | Multiple System Atrophy | - | - |
Foralumab | Phase 2 | Secondary Progressive Multiple Sclerosis | - | - |
Foralumab TZLS-401 | Phase 2 | Non-Active Secondary Progressive Multiple Sclerosis | - | - |
Milciclib maleate | Phase 2 | Hepatocellular Carcinoma | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Tiziana Life Sciences Ltd's drug pipeline?→
CatalystAlert tracks 4 drug candidates in Tiziana Life Sciences Ltd's (TLSA) pipeline across Phase 2. Its lead program is Foralumab Nasal (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Tiziana Life Sciences Ltd's next FDA catalyst?→
Tiziana Life Sciences Ltd's (TLSA) next tracked catalyst is a Phase 2 readout expected April 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TLSA biotech catalysts?→
Add TLSA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Tiziana Life Sciences Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.